本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Navidea生物製藥

0.0005
0.0000
成交量:1,075.00
成交額:0.54
市值:5.00萬
市盈率:-0.02
高:0.0005
開:0.0005
低:0.0005
收:0.0005
52周最高:0.1300
52周最低:0.0001
股本:9,999.44萬
流通股本:6,407.24萬
量比:0.48
換手率:0.00%
股息:- -
股息率:- -
每股收益(TTM):-0.0260
每股收益(LYR):-0.5571
淨資產收益率:-1100.12%
總資產收益率:-107.05%
市淨率:-0.02
市盈率(LYR):0.00

資料載入中...

2024/02/05

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/27

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/27

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/27

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/27

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/27

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/26

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/26

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/26

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/26

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/26

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/17

交易所摘牌聲明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/12/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/21

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/02

重要事件披露

Form 8-K - Current report
2023/11/17

重要事件披露

Form 8-K - Current report
2023/11/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/24

交易所摘牌聲明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/09/07

SEC問詢函

Form CORRESP - Correspondence
2023/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]